The effect of antireticular cytotoxic serum on the aorta elasticity in sclerous systolic hypertension

V. I. Titov , F. F. Shchukina

Kazan medical journal ›› 1987, Vol. 68 ›› Issue (4) : 263 -264.

PDF
Kazan medical journal ›› 1987, Vol. 68 ›› Issue (4) : 263 -264. DOI: 10.17816/kazmj96129
Articles
research-article

The effect of antireticular cytotoxic serum on the aorta elasticity in sclerous systolic hypertension

Author information +
History +
PDF

Abstract

It is known that pathogenesis of stable isolated sclerotic hypertension in elderly and senile patients is mainly caused by decreased elastic properties of aorta and large arteries due to age-related and, to a lesser extent, atherosclerotic changes. Loss of elasticity impairs the adaptive capacity of the circulatory system, leads to increased energy expenditure per unit minute volume, and left ventricular myocardial hypertrophy. Sclerotic systolic hypertension is a risk factor for, firstly, cerebral strokes, increasing their frequency from 2 to 4 times, and secondly, myocardial infarctions, worsening their prognosis. Therefore, at the present time it is reasonable to strive for BP normalization in sclerotic systolic hypertension in old age and old age. Meanwhile, hypotensive drug therapy of systolic hypertension is ineffective, because it is aimed not on the primary, but on the secondary links of blood pressure regulation. Thus, vasodilators, which reduce peripheral resistance, saluretics, which reduce circulating fluid volume, beta-adrenoblockers, which reduce cardiac output, only temporarily reduce systolic pressure. Vigorous and persistent therapy with these medications can lead to a significant reduction in blood flow to the brain and other regions.

Keywords

Kazan Medical archive

Cite this article

Download citation ▾
V. I. Titov, F. F. Shchukina. The effect of antireticular cytotoxic serum on the aorta elasticity in sclerous systolic hypertension. Kazan medical journal, 1987, 68(4): 263-264 DOI:10.17816/kazmj96129

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Ганжа И. М., Мягкова И. П.//Врач. дело.— 1977.— № 1.— С. 47—51.

[2]

Ланг Г. Ф.//Гипертоническая болезнь.— Л., Медгиз, 1950.

[3]

Мясников А. Л.//Гипертоническая болезнь и атеросклероз.— М., Медицина, 1965.

[4]

Титов В. И.//Особенности клиники и диагностики ишемической болезни сердца и артериальной гипертонии в пожилом и старческом возрасте.— Автореф. докт. дисс.— М., 1979.

[5]

Титов В. И., Яковлева З. М.// В кн.: Материалы итоговой научной конференции 4-го ГУ при М3 СССР.— М., 1977.

[6]

Токарь А. В.//Артериальная гипертония и возраст.— Киев, Здоров’я, 1977.

[7]

Цфасман А. З.//Систолическая гипертония у людей старших возрастов.— М., Медицина, 1985.

[8]

Berkman M., Magnier J. Р., Tran М. D., Jhilland Р.//Am. Heart J.— 1979.— Vol. 97.— P. 131—132.

[9]

Iwatsuki K., Cardinale G. J., Spector S., Underfriend S.//Proc. Natl. Acad. Sci. USA.— 1977.— Vol. 74.— P. 360.

[10]

Kannel W. B., Wolf P. A., Mc Gree D. L. et al.//J.A.M.A.— 1981.— Vol. 245.— P. 1225.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

108

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/